Conversely, another paper suggests that the TET1 gene is a direct target of MLL (mixed leukemia) fusion proteins, and its expression is strongly enhanced during the progression of MLL-induced leukemia, thus inducing an overall increase in the amount of hm5C [152]. This evidence concerns the gene KMT2A and leukemia.